Executive committee members
Ali Andalibi, Ph.D.
Associate Dean for Research, College of Science, George Mason University
Inflammatory diseases – genetics and drug discovery. More →
Paul R. Carlier, Ph.D.
Professor, Chemistry, Virginia Tech
Drug Design for depression, Alzheimer’s Disease, Malaria. More →
Umesh Desai, Ph.D.
Professor, Institute for Structural Biology, Drug Discovery & Development, Virginia Commonwealth University
Glycosaminoglycans and mimetics as modulators of coagulation, cancer, inflammation, emphysema and viral infection
Marion Ehrich, R.Ph., Ph.D., DABT, ATS
Professor of Pharmacology/Toxicology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, and Virginia Tech School of Medicine
Nick Farrell, Ph.D.
Professor of Chemistry, VCU
Platinum, anticancer drugs, zinc fingers, metalloglycomics. More →
Paul B. Fisher, M.Ph., Ph.D., FNAI
Professor and Chair, Department of Human and Molecular Genetics, VCU Director, VCU Institute of Molecular Medicine
B. Frank Gupton, Ph.D.
Chair and Professor, Department of Chemical and Life Science Engineering at VCU
Flow Chemistry, Catalysis, Active Pharmaceutical Ingredients More →
John Lazo, Ph.D.
Harrison Distinguished Professor of Pharmacology and Chemistry, Associate Director for Basic Science at the UVA Cancer Center, University of Virginia
Pharmacology, Chemical-Biology, Phosphatases, Cancer, Alzheimer’s disease. More →
Mikell Paige, Ph.D.
Associate Professor, Department of Chemistry and Biochemistry
Drug Discovery, Pulmonary Inflammation, Fibrosis, Traumatic Brain Injury, Medicinal Chemistry, Organic Synthesis, Enzymology, Protein Chemistry
Elizabeth Sharlow, Ph.D.
Associate Professor of Research, Department of Pharmacology; Co-Director, Fiske Drug Discovery Laboratory, University of Virginia
Chemical Biology, Phosphatases, Cancer, High Throughput Screening, Assay Development